We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+11.06%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$261B
AUM Growth
+$19.9B
Cap. Flow
-$3.39B
Cap. Flow %
-1.3%
Top 10 Hldgs %
22.36%
Holding
2,965
New
219
Increased
1,218
Reduced
1,020
Closed
126

Top Buys

Rank Stock Value
1
SHOP icon
Shopify
SHOP
+$873M
2
AAPL icon
Apple
AAPL
+$739M
3
ACN icon
Accenture
ACN
+$450M
4
IWS icon
iShares Russell Mid-Cap Value ETF
IWS
+$393M
5
CRM icon
Salesforce
CRM
+$359M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.39B
2
INFY icon
Infosys
INFY
+$641M
3
META icon
Meta Platforms (Facebook)
META
+$621M
4
JPM icon
JPMorgan Chase
JPM
+$483M
5
V icon
Visa
V
+$477M

Sector Composition

Rank Sector Weight
1 Technology 28.05%
2 Healthcare 12.84%
3 Consumer Discretionary 11.61%
4 Financials 11.34%
5 Communication Services 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTHX
2526
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$419K ﹤0.01%
41,011
KNSA icon
2527
Kiniksa Pharmaceuticals
KNSA
$5.93B
$418K ﹤0.01%
35,490
FPH icon
2528
Five Point Holdings
FPH
$375M
$411K ﹤0.01%
62,917
UMC icon
2529
United Microelectronic
UMC
$46.9B
$410K ﹤0.01%
35,000
ICPT
2530
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$409K ﹤0.01%
25,109
AKBA icon
2531
Akebia Therapeutics
AKBA
$252M
$409K ﹤0.01%
180,790
+6,617
+4% +$18K
WGS icon
2532
GeneDx Holdings
WGS
$2.3B
$394K ﹤0.01%
+2,679
New +$599K
KLRS
2533
Kalaris Therapeutics
KLRS
$96.8M
$393K ﹤0.01%
1,321
+142
+12% +$65.9K
XENT
2534
DELISTED
Intersect ENT, Inc
XENT
$388K ﹤0.01%
14,198
-11,329
-44% -$307K
HIPO icon
2535
Hippo Holdings
HIPO
$861M
$388K ﹤0.01%
+5,480
New +$511K
WKHS icon
2536
Workhorse Group
WKHS
$36.3M
$387K ﹤0.01%
30
+1
+3% +$18.2K
AERI
2537
DELISTED
Aerie Pharmaceuticals
AERI
$385K ﹤0.01%
54,793
LGO
2538
Largo
LGO
$70.9M
$384K ﹤0.01%
41,333
TTCF
2539
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$382K ﹤0.01%
24,572
+9,472
+63% +$162K
AXGN icon
2540
Axogen
AXGN
$2.5B
$382K ﹤0.01%
40,741
LPG icon
2541
Dorian LPG
LPG
$1.96B
$382K ﹤0.01%
30,065
SANA icon
2542
Sana Biotechnology
SANA
$980M
$381K ﹤0.01%
+24,600
New +$474K
HYZN
2543
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$380K ﹤0.01%
+1,170
New +$381K
MFG icon
2544
Mizuho Financial
MFG
$130B
$379K ﹤0.01%
+148,535
New +$392K
BRY
2545
DELISTED
Berry Corp
BRY
$376K ﹤0.01%
+44,600
New +$393K
DTIL icon
2546
Precision BioSciences
DTIL
$207M
$373K ﹤0.01%
1,678
FBRT
2547
Franklin BSP Realty Trust
FBRT
$657M
$372K ﹤0.01%
+24,916
New +$402K
APR
2548
DELISTED
Apria, Inc. Common Stock
APR
$369K ﹤0.01%
+11,329
New +$367K
OLO
2549
DELISTED
Olo Inc
OLO
$368K ﹤0.01%
+17,700
New +$460K
VVNT
2550
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$367K ﹤0.01%
37,530
-27,448
-42% -$269K

Similar funds

UBS AM's Q4 2021 Portfolio in Review

As of Q4 2021, UBS AM held 2,965 positions worth $261B, up 8.3% from $241B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS AM's Q4 2021 filing shows 219 new, 1,218 increased, 1,020 reduced and 126 closed positions. Its largest new stake was iShares Russell Mid-Cap Value ETF: 3,293,120 shares worth $403M. The largest sale was Microsoft, an estimated $1.39B.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • UBS AM's largest Q4 2021 buy was iShares Russell Mid-Cap Value ETF: 3,293,120 shares worth $403M.
  • UBS AM added most to Shopify in Q4 2021, an estimated $873M increase.
  • UBS AM's biggest Q4 2021 reduction was Microsoft, cutting an estimated $1.39B.
  • UBS AM fully exited Baidu in Q4 2021, selling an estimated $360M.
  • UBS AM's ten largest holdings make up 22% of its $261B portfolio in Q4 2021.
  • UBS AM opened 219 new positions and closed 126 in Q4 2021.
  • UBS AM's portfolio value rose 8.3% quarter-over-quarter to $261B.

Based on UBS AM's 13F filing for Q4 2021, filed 14 Feb 2022.